Research ArticleCardiovascular
A TRPC3 Blocker, Ethyl-1-(4-(2,3,3-Trichloroacrylamide)Phenyl)-5-(Trifluoromethyl)-1H-Pyrazole-4-Carboxylate (Pyr3), Prevents Stent-Induced Arterial Remodeling
Sarah Koenig, Michaela Schernthaner, Heinrich Maechler, C. Oliver Kappe, Toma N. Glasnov, Gerald Hoefler, Marlen Braune, Eric Wittchow and Klaus Groschner
Journal of Pharmacology and Experimental Therapeutics January 2013, 344 (1) 33-40; DOI: https://doi.org/10.1124/jpet.112.196832
Sarah Koenig
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
Michaela Schernthaner
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
Heinrich Maechler
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
C. Oliver Kappe
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
Toma N. Glasnov
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
Gerald Hoefler
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
Marlen Braune
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
Eric Wittchow
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
Klaus Groschner
Institute of Biophysics (S.K., M.S., K.G.), Department of Cardiac Surgery (H.M.), Institute of Pathology, Medical University of Graz, Graz, Austria (G.H.); Institute of Chemistry, Karl-Franzens-University of Graz, Graz, Austria (C.O.K., T.N.G); and Vascular Interventions R&D group, BIOTRONIK SE & Co. KG., Erlangen, Germany (M.B., E.W.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
TRPC3 as a Novel Target for Drug-Eluting Stent Strategies
Sarah Koenig, Michaela Schernthaner, Heinrich Maechler, C. Oliver Kappe, Toma N. Glasnov, Gerald Hoefler, Marlen Braune, Eric Wittchow and Klaus Groschner
Journal of Pharmacology and Experimental Therapeutics January 1, 2013, 344 (1) 33-40; DOI: https://doi.org/10.1124/jpet.112.196832
Research ArticleCardiovascular
TRPC3 as a Novel Target for Drug-Eluting Stent Strategies
Sarah Koenig, Michaela Schernthaner, Heinrich Maechler, C. Oliver Kappe, Toma N. Glasnov, Gerald Hoefler, Marlen Braune, Eric Wittchow and Klaus Groschner
Journal of Pharmacology and Experimental Therapeutics January 1, 2013, 344 (1) 33-40; DOI: https://doi.org/10.1124/jpet.112.196832
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement